UCB to partner with Novartis on development of UCB0599 with an opt-in to develop UCB7853, two innovative and potentially disease-modifying investigational assets in Parkinson's disease
/PRNewswire/ UCB today announced that it has entered into a global co-development and co-commercialization agreement with Novartis covering UCB0599, a.
Cyclerion Therapeutics Reports Second Quarter 2021 Financial Results and Corporate Update streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Form DEF 14A Savara Inc For: Jun 10 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.